top of page
Recent News & Press Releases
Search
CMT Research Foundation Invests in Asha Therapeutics to Test Novel Drug for CMT2A
ATLANTA, GA, UNITED STATES, May 20, 2025 /EINPresswire.com/ -- CMT Research Foundation has invested in a research project with Asha...
EIN Presswire
May 202 min read
Advancium Health Network Catalyzes Research on an Innovative SARM1 Inhibitor in a Rare Eye Disease
NEW YORK, April 23, 2025 /PRNewswire/ -- Advancium Health Network, a public charity dedicated to advancing therapies for rare diseases,...
PR Newswire
Apr 233 min read
Asha Therapeutics Awarded Barnett Drug Development Grant by the ALS Association and Announces Appointment of Disarm Therapeutics’ Founders to SAB
November 13, 2024 09:30 AM Eastern Standard Time CINCINNATI--( BUSINESS WIRE )-- Asha Therapeutics  (Asha), a life sciences company...
Business Wire
Nov 13, 20245 min read
Asha Therapeutics Announces the Nomination of a Novel Intra-Molecular Glue Development Candidate ASHA-624 as a Disease Modifying Therapeutic for Amyotrophic Lateral Sclerosis
CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha) (www.ashatherapeutics.com), a life sciences company designing de novo disease...
Business Wire
Apr 1, 20243 min read
Asha Therapeutics to Present at AD/PDâ„¢ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year
CINCINNATI--(BUSINESS WIRE)--Asha Therapeutics (Asha), (www.ashatherapeutics.com), a life sciences company, is leveraging its...
Business Wire
Mar 9, 20244 min read
Asha Therapeutics Selected as a BLUE KNIGHTâ„¢ Company by Johnson & Johnson Innovation and BARDA
Asha Therapeutics (Asha), (www.ashatherapeutics.com), a biopharmaceutical company revolutionizing the traditional multi-year drug...
PR Newswire
Sep 22, 20233 min read
bottom of page